Galiximab (IDEC 114), a primatized IgG1 lambda monoclonal antibody, targets the CD80 antigen. It combines primatized (cynomologous monkeys) variable regions with human constant regions. This compound is utilized in the study of B-cell lymphoma [1].
CAS Number:
[357613-77-5]
* VAT and and shipping costs not included. Errors and price changes excepted
